Dragged down by lower growth of anti-infectives segment and rise in employee cost, GlaxoSmithKline (GSK) Pharmaceuticals today reported 7.57% decline in net profit for the third quarter ended September 30, 2011 to Rs 145.86 crore over the same period last fiscal. Settlement Cash Structured For Flow
Dragged down by lower growth of anti-infectives segment and rise in employee cost, GlaxoSmithKline (GSK) Pharmaceuticals today reported 7.57% decline in net profit for the third quarter ended September 30, 2011 to Rs 145.86 crore over the same period last fiscal.
ReplyDeleteSettlement Cash Structured For Flow